News about Clinical Trials

Shuttle Pharma Finalizes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine

Shuttle Pharma Finalizes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine

Ropidoxuridine (IPdR) is Shuttle Pharma's lead candidate radiation sensitizer for use in combination with RT to treat brain tumors (glioblastoma), a deadly malignancy of the brain with no known cure.

Clinical Trials | 29/10/2024 | By Aishwarya

Unravel Biosciences and PECET to Conduct Clinical Trials of RVL-001 in Rett Syndrome in Colombia

Unravel Biosciences and PECET to Conduct Clinical Trials of RVL-001 in Rett Syndrome in Colombia

Unravel's proprietary BioNAV drug discovery platform identified RVL-001 as a potentially promising therapeutic drug for Rett Syndrome and PTHS.

Clinical Trials | 25/10/2024 | By Aishwarya

Evergreen Theragnostics Opens Phase II Small Cell Lung Cancer Clinical Trial in EU

Evergreen Theragnostics Opens Phase II Small Cell Lung Cancer Clinical Trial in EU

The CCK2-VIEW trial uses 68Ga-EVG321, a peptide-based Radioligand imaging agent administered to patients with small cell lung cancer.

Clinical Trials | 18/10/2024 | By Aishwarya

Eximia Research Acquires Integrated Clinical Trial Services

Eximia Research Acquires Integrated Clinical Trial Services

With this expansion into Iowa, this partnership marks another significant milestone in Eximia's mission to broaden access to cutting-edge clinical trials and innovative healthcare solutions across the nation.

Clinical Trials | 17/10/2024 | By Aishwarya

GBI and Allterum to Manufacture Therapeutic Antibody for Clinical Trials

GBI and Allterum to Manufacture Therapeutic Antibody for Clinical Trials

With this collaboration, GBI will leverage their extensive expertise in manufacturing complex biologics to ensure the high-quality production of 4A10 for Phase 1/2a clinical trials.

Clinical Trials | 08/10/2024 | By Aishwarya

CD Biopharma Receives FDA Clearance for Phase I Clinical Trial of CD-001

CD Biopharma Receives FDA Clearance for Phase I Clinical Trial of CD-001

CD-001, the company's clinical candidate, is built on its proprietary Bispecific Fusion Protein (BsFP) platform.

Clinical Trials | 20/09/2024 | By Aishwarya

GC Biopharma, Hanmi Pharma Secure IND Clearance for Phase 1/2 Clinical Trial

GC Biopharma, Hanmi Pharma Secure IND Clearance for Phase 1/2 Clinical Trial

LA-GLA is an innovative new drug for the treatment of Fabry disease as the world's first once-monthly subcutaneous treatment, which is being co-developed by GC Biopharma and Hanmi Pharmaceutical.

Clinical Trials | 03/09/2024 | By Aishwarya

Sanofi Reveals Positive Results of Tolebrutinib in HERCULES Phase 3 Study

Sanofi Reveals Positive Results of Tolebrutinib in HERCULES Phase 3 Study

In the HERCULES study, nrSPMS was defined at baseline as having an SPMS diagnosis with an expanded disability status scale (EDSS) score between 3.0 and 6.5, no clinical relapses for the previous 24 months and documented evidence of disability accumulation in the previous 12 months.

Clinical Trials | 03/09/2024 | By Aishwarya

Grit Biotechnology Secures IND Clearance for GT201 from US FDA

Grit Biotechnology Secures IND Clearance for GT201 from US FDA

GT201, an advanced genetically engineered TIL product developed by Grit Biotechnology's platforms StemTexp and StaViral, boosts T cell survival and function by expressing a vital membrane-bound cytokine complex.

Clinical Trials | 02/09/2024 | By Aishwarya

Mabwell Gets CDE Approval to Initiate Phase III Clinical Trial of 9MW2821

Mabwell Gets CDE Approval to Initiate Phase III Clinical Trial of 9MW2821

9MW2821 is a novel Nectin-4-targeting ADC independently developed by Mabwell, and it is the first of its kind in China to initiate clinical trials on the same target, with more than 400 subjects enrolled in the clinical studies for multiple indications.

Clinical Trials | 27/08/2024 | By Aishwarya

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members